Market Research Blog – Page 1202 – New Product Development

Global Medical X-Ray Detectors Market Projected to Reach USD 3.2 Billion by 2029, Growing at 5.7% CAGR

The global medical X-ray detectors market is poised for significant growth, with a projected expansion at a CAGR of 5.7%. The market is expected to increase from a valuation of USD 2.2 billion in 2022 to USD 3.2 billion by 2029.

The rising prevalence of chronic diseases and the growing need for advanced diagnostic imaging technologies are key drivers propelling the demand for medical X-ray detectors. These devices play a crucial role in providing accurate and efficient imaging, which is essential for effective patient diagnosis and treatment.

The market’s upward trajectory is driven by several key factors, including advancements in X-ray technology, rising demand for high-quality diagnostic imaging, and increasing adoption of digital X-ray systems. These developments are enhancing the efficiency and accuracy of medical imaging, contributing to the growing market.

As healthcare providers continue to invest in state-of-the-art diagnostic equipment to improve patient outcomes and streamline imaging processes, the medical X-ray detectors market is expected to experience sustained growth. The shift towards digital and advanced imaging technologies is further supporting market expansion.

The surge in the medical devices industry, particularly in imaging and diagnostic tests, is a key catalyst for this anticipated growth. Factors contributing to this upswing include a heightened focus on radiological diagnostic tests, an increasing burden of chronic diseases, and the advent of more efficient X-ray devices facilitated by consolidation and mergers in the medical devices market.

The Centers for Disease Control & Prevention (CDC) estimates that around 80 million Computed Tomography (CT) tests were performed in 2015 in the U.S. alone. A rise in some patients undergoing CT and radiography tests globally and an increase in several tests performed each year have led to significant demand for digital radiography detectors such as a-Si detectors. These factors have boosted the demand for a-Si X-ray flat panel detectors, directly fueling the growth of the Global Medical X-ray detectors Industry.

Key Takeaways – Medical X-Ray Detectors Market Study

Adoption of flat panel X-ray detectors in the global medical X-ray detectors market has increased significantly owing to distinct benefits over computed radiography (CR), charged couple detectors (CCD), and analog detectors (film based).
Introduction of new technology such as Veradius X–ray system by manufacturers is expected to boost demand for thin flat detector devices and computed radiography (CR) detectors among end users.
Direct flat-panel medical X-ray detectors with comparatively higher technical advantage over indirect flat-panel medical X-ray detectors are expected to generate significant revenue.
Increasing adoption of digital X-ray systems for radiological imaging as compared to retrofit X-ray systems marks high revenue potential for the medical X-ray detectors market.

Cloud-based medical imaging and the growing shift from analog to digital X-ray detectors are key growth opportunities for the Global Medical X-ray detectors Market.

Strategic Acquisitions Remains Favored Competition Strategy

Leading players in the medical X-ray detectors market such as GE Healthcare, Canon, Philips, and Hitachi, are focusing on business expansions by entering into partnerships, mergers, sales agreements, and acquisitions with local manufacturers from emerging economies. The aim behind these mergers and acquisitions is to reduce product development costs, streamline the distribution channel, and strengthen the market position.

In December 2016, Canon Inc. acquired the Toshiba Corp. medical unit. With the acquisition, Canon Inc. entered into the diagnostics imaging devices market and leveraged the core strength of Toshiba Medicals in diagnostic imaging. This acquisition would further strengthen Canon’s biomedical business.

Additionally, key players are focusing on research and development and the launch of new products based on exclusive developmental technologies, with an emphasis on product differences. In November 2017, at the Radiological Society of North America (RSNA) tradeshow. Carestream Health showcased a mobile X-ray system with a carbon nanotube. The system entered the medical X-ray detectors market in May 2018 and is compatible with every DRX a-Si detector device provided by Carestream Health.

Know More About FMI’s Report on Global Medical X-Ray Detectors Industry

Future Market Insights brings a comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the segments from 2014 to 2029. The Global Medical X-Ray Detectors Industry is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the Global Medical X-Ray Detectors Industry based on product, panel size, modality, and end user.

A Old Full Report Analysis Click Here

Medical X-Ray Detectors Market By Category By Product :

Indirect Flat-Panel Detectors
Direct Flat-Panel Detectors
Computed Radiography (CR) Detectors

By Panel Size :

Large-Area Flat-Panel Detectors
Small-Area Flat-Panel Detectors

By Modality :

Portable Detectors
Fixed Detectors

By Module Type :

Digital X-ray Systems
Retrofit X-ray Systems

By End User :

Hospitals
Diagnostic Centers

By Region :

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East & Africa

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Dosimetry Market Projected to Reach USD 4,882.60 Million by 2034 at a 4.5% of CAGR

In a recently updated edition of the dosimetry market report, Future Market Insights (FMI) has assessed the market valuation to be USD 3,144.10 million in 2024. The market is experiencing significant growth driven by increasing incidences of conditions such as cardiovascular diseases (CVD), cancer, and neurology-related disorders, which are raising the demand for accurate dosimeters.

The dosimetry market is anticipated to reach a valuation of USD 4,882.60 million by 2034, expanding at an average growth rate of 4.5% during the forecast period. As healthcare providers and researchers prioritize precision in treatment delivery, the demand for advanced dosimetry solutions continues to rise.

The growth in the dosimetry market is being fueled by the increasing prevalence of chronic conditions such as cardiovascular diseases (CVD), cancer, and neurology-related disorders. These conditions are driving the demand for precise dosimetry solutions, which are crucial for monitoring and managing radiation exposure in medical treatments and research.

Key players in the dosimetry market are focusing on enhancing their product offerings and improving service delivery to capture a larger share of this growing market. Technological advancements and the development of more efficient and accurate dosimeters are driving market expansion.

Key Takeaways:

Market Valuation: The global dosimetry market was valued at US$3,144.10 million in 2024, with a projected growth to US$4,882.60 million by 2034, reflecting an average growth rate of 4.5%.
Rising Disease Prevalence: Increasing incidences of cardiovascular diseases, cancer, and neurology-related disorders are driving the demand for dosimeters, emphasizing the importance of radiation safety and monitoring in healthcare and other industries.
Market Expansion: The dosimetry market continues to expand as players enhance their product offerings and elevate service delivery to cater to the growing demand for radiation safety solutions in diverse sectors.
Innovation and Product Enhancement: Industry players are focusing on innovation and product enhancement to gain a greater share in the growing dosimetry market, offering advanced dosimeters with improved features and capabilities.
Role in Radiation Safety: Dosimeters play a critical role in radiation safety by providing real-time monitoring and actionable insights to mitigate health risks associated with radiation exposure, ensuring occupational safety and regulatory compliance.

Acquisition Key Strategy Followed by Leading Manufacturers:

Leading manufacturers in the Dosimetry market are focusing on the acquisition strategy to enhance their product portfolio and expand their regional presence. For instance, in 2017, Fortive acquired Landauer, a leading global provider of subscription-based technical and analytical services to determine occupational and environmental radiation exposure.

In 2016, Mirion Technologies Inc. acquired Canberra Industries. Mirion’s acquisition of Canberra brings together two of the most respected and experienced industry players, and offers comprehensive and compelling solutions for the global customer base.

Major Players are:

Honeywell
Fisher Scientific Inc.
Landauer, Inc. (Fortive)
Mirion Technologies Inc.
Fuji Electric Corporation of America
Polimaster Inc.
JP Laboratories Inc

Want more insights on the Dosimetry market?

A new study by Future Market Insights opines on the evolution of the Dosimetry market from 2014 to 2021, and presents demand projections for 2022 to 2029, on the basis of product (personal electronic dosimeters, self-reading dosimeters, processed dosimeters), modality (wearable and non-wearable), energy (active dosimeters and passive dosimeters), and end user (industrial, medical, oil and gas, defence, homeland security, mining, environmental, others), across seven prominent regions.

A Old Full Report Analysis Click Here

Dosimetry Market by Category

By Product Type:

Personal Electronic Dosimeter
Self-reading Dosimeters
Processed Dosimeters

By Modality:

Wearable
- Collar level
- Chest level
- Waist level
- Wrist level
- Finger level
Non-wearable

By Energy:

Active Dosimeters
Passive Dosimeters
- Optically Stimulated Luminescence Dosimeter (OSLD)
- Thermoluminescence Dosimeters (TLD)
- Radiophotoluminescence (RPL)

By End User:

Industrial
Medical
Oil and Gas
Defense, Homeland Security
Mining
Environmental
Others

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Tissue Engineered Skin Substitute Market Projected to Reach USD 3.5 Billion by 2034, Growing at 3.9% CAGR

The global tissue engineered skin substitute market is set for substantial growth, projected to be valued at USD 2.4 billion in 2024 and anticipated to reach USD 3.5 billion by 2034. The market is expected to expand at a CAGR of 3.9% during the forecast period from 2024 to 2034.

The anticipated market expansion is driven by increasing demand for advanced skin substitutes, which are essential for treating severe skin injuries, burns, and chronic wounds. Tissue engineered skin substitutes offer innovative solutions that enhance wound healing and improve patient outcomes, further supporting market growth.

As a result of tissue engineering and the improved ability to combine modern manufacturing methods with biomaterials and cell culture systems, more biomimetic tissue structures have emerged. Technological advancements are opening the path for improved tissue created skin substitutes. Biotextiles and 3D bioprinting are emerging as appealing biofabrication technologies for the development of bioengineered skin substitutes. A team of researchers in the United States has developed a technology that allows for the complete 3D printing of living skin and blood vessels. The introduction of such cutting-edge fabrication technologies will create a substantial potential in the global market.

Despite breakthrough developments that have aided market growth, certain constraints remain. One of the most significant difficulties facing R&D teams is the incapacity of tissue created skin substitutes to produce skin appendages such as hair follicles, sebaceous glands, and nails.

Key Takeaways – Tissue Engineered Skin Substitute Market Study

Demand for biologic skin substitutes is expected to rise during the forecast period due to increased tissue engineering research. Engineers from Caltech and ETH Zurich, for example, developed an artificial skin out of pectin, a naturally occurring long-chain polymer found in plant cell walls that allows the production of natural and fresh dermis.
Diabetes and chronic wounds are growing increasingly widespread, resulting in an increase in demand for tissue engineered skin substitutes.
The incidence of diabetic foot ulcers, venous leg ulcers, and pressure ulcers is expected to drive demand for tissue engineered skin substitutes in developing nations such as China and India.

Leading Manufacturers Setting the Pace for Product Innovations

The tissue engineered skin substitute market is a consolidated market. The tier 1 companies in the tissue engineered skin substitute market such as Allergan Plc., Mimedex Group Inc., Integra LifeSciences Corp. and Integra LifeSciences Corp. are expected to hold more than half of the total revenue generated by tissue engineered skin substitutes. The key players in the market are reshaping their current product portfolio by focusing on the introduction of new and advanced technologies and innovating new products.

Key Players:

Smith & Nephew plc.
Acelity L.P. Inc.
Mölnlycke Health Care
Integra Life Sciences
Allergan plc
Regenicin
Organogenesis Inc.
MiMedx
LifeNet Health
Kerecis
Medline Industries, Inc.

Seeking More Insights?

Tissue engineered skin substitute market, a new study from Future Market Insights, opines on the evolution of tissue engineered substitute market from 2014 to 2021 and presents demand projections from 2022 to 2029 on the basis of; product (acellular skin substitute, biologic skin substitute, cellular skin substitute and synthetic substitute), material (synthetic and natural), application (chronic wound, acute wound and other applications such as breast reconstruction etc.) and end user (hospital, specialty clinics, ambulatory surgical centres and research laboratories) across seven prominent regions.

A Old Full Report Analysis Click Here

Tissue Engineered Skin Substitute Market by Category

By Product:

Acellular Skin Substitutes
- Acellular skin substitutes based on Amniotic Membrane
- Other Acellular skin substitutes
Biologic Skin Substitute
- Allograft
- Xenograft
Cellular Skin Substitutes
- Cellular skin substitute based on amniotic membrane
- Other cellular skin substitutes

Synthetic Skin Substitutes

By Material:

Synthetic
Natural

By Application:

Chronic Wounds
- Venous leg Ulcers
- Diabetic Foot Ulcer
- Pressure Ulcers
Acute Wounds
- Traumatic Wounds
- Burn Cases
Other Applications

By End User:

Hospital
Specialty Clinics
Ambulatory Surgical Centers
Research Laboratory

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Global Implantable Drug Eluting Devices Market Share to Reach USD 12.8 Billion by 2029, Growing at 6.0% CAGR

The global implantable drug eluting devices market is poised for substantial growth, with a projected CAGR of 6.0% from 2022 to 2029. The market was valued at approximately USD 12.8 billion in 2022, according to recent projections by Future Market Insights.

Among the various product categories, contraceptive drug eluting devices have demonstrated significant market presence, holding a substantial share of over 39.8% in 2021. These devices provide a reliable and effective means of contraception, contributing to their growing adoption worldwide.

A significant contributor to this growth is the substantial market share held by contraceptive drug eluting devices, which represented over 39.8% of the market in 2021. This highlights the growing adoption of implantable devices for contraceptive purposes, driven by their effectiveness and convenience in long-term birth control.

In a noteworthy trend, manufacturers leading the industry are harnessing advancements in micro and nanotechnology to craft innovative implantable drug-eluting devices, steering the industry towards unprecedented growth. These cutting-edge devices exhibit controlled and site-specific attributes, along with compatibility for targeted drug delivery. This unique combination not only simplifies intricate dosing schedules but also mitigates the systemic toxicity associated with conventional drug delivery systems.

Remote-Controlled Chips and Programmable Devices – Future of Targeted Drug Delivery

Increasing clinical trials and research & development of remote-controlled and programmable drug-eluting devices Massachusetts Institute of Technology (MIT) researchers have developed a remote-controlled contraceptive hormone (levonorgestrel) delivery chip implant, which can turn the device on and off. Implantable drug-eluting devices allow minimum effective doses and support oral opioid weaning

Implantable drug-eluting devices such as SynchroMed II intrathecal drug delivery system with a controlled workflow system, play an effective role in reducing or eliminating the use of oral opioids. Antiretroviral (ARV) drug implant is expected to emerge as a promising approach for HIV treatment and prevention In July 2022, Merck & Co. started the development of slow-release antiretroviral (ARV) drug implants as a promising approach for HIV treatment.

The growth of the Global Implantable Drug Eluting Devices Industry can be prominently attributed to the associated cost-effective technology and novel medication administration techniques. Fewer side effects while these devices are utilized in the management of chronic diseases as well as in contraception have been the strongest attribute accounting for a steadily expanding market for implantable drug-eluting devices. Says Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)

Know More About Global Implantable Drug-Eluting Devices Industry Report

The Global Implantable Drug-Eluting Devices Industry, a new study from Future Market Insights, opines on the evolution of the implantable drug-eluting devices market from 2014 – 2021 and presents demand projections from 2022 – 2029 based on product type (implantable drug infusion pumps, intraocular drug-eluting devices, contraceptive drug-eluting devices, buprenorphine implant, and drug-eluting stents), technology (active drug-eluting devices and passive drug-eluting devices) applications (diabetes macular edema, birth control/contraception, opioid addiction, cardiovascular, ophthalmology, oncology, pain management, others) implantation type (intravaginal, intravascular, intraocular, intrathecal, subcutaneous, intrauterine) end users (hospitals, ambulatory surgical centers, optical care centers, cardiac surgery centers, office-based setting, and others) in seven prominent regions.

Medical-Pharma Collaborating to Balance Demand and Supply

A comprehensive view of the Global Implantable Drug Eluting Devices Industry has led our analysts to conclude that, the market is expected to grow at an impressive rate. This market growth is mainly attributed to increasing innovations and developments in implantable drug-eluting devices for the management and treatment of breast cancer, schizophrenia, Parkinson’s disease, and photosensitivity diseases. Besides, FMI analyst suggests that markets in North America and Europe are expected to hold major value shares in the global implantable drug-eluting devices landscape. Medical device companies are collaborating with pharmaceutical companies to develop efficient drug-delivery devices to cater to the rising demand for implantable drug-eluting devices.

Increasing use of syringe-based subcutaneous implantable drug-eluting devices is anticipated to minimize the number of invasive surgical procedures. The introduction of implantable drug-eluting devices or rare conditions such as central precocious puberty (CPP) will emerge as an important factor shaping the market for implantable drug-eluting devices.

A Old Full Report Analysis Click Here

Key Segments Covered in Global Implantable Drug-Eluting Devices Industry Research

By Product:

Implantable Drug Infusion Pumps
Intraocular Drug-Eluting Devices
Contraceptive Drug-Eluting Devices
Buprenorphine Implant
Drug-Eluting Stents
Others

By Technology:

Active Drug Eluting Device
Passive Drug Eluting Device
- Biodegradable Implants
- Non-Biodegradable Implants

By Application:

Diabetic Macular Edema
Birth Control/Contraception
Opioid Addiction
Cardiovascular
Ophthalmology
Oncology
Pain Management

Author

Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Global Pressure Infusion Bags Market share Projected to Reach USD 494.5 Million by 2029

The global pressure infusion bags market was valued at USD 300.0 million in 2021 and is anticipated to reach USD 494.5 million by 2029. This growth reflects the increasing demand for effective fluid delivery systems in medical settings.

Pressure infusion bags are critical in emergency and surgical environments, facilitating rapid fluid infusion to patients. The rising prevalence of chronic diseases and the growing need for emergency medical services are driving the demand for these essential devices.

The anticipated growth in the pressure infusion bags market is driven by increasing demand for efficient and effective infusion solutions in medical procedures. Pressure infusion bags are crucial for administering fluids rapidly and precisely, which is vital in emergency care and surgical settings.

Pressure infusion cuffs are designed cuff and bladder device used to pressurize sterile parenteral fluids for rapid infusion into the body. These decrease the infusion time to a few seconds from hour taken by gravity fed blood infusion. The need for rapid infusion of solutions and monitoring of invasive procedures involving pressure are the prime applications of pressure infusion bags. The growing frequency of intra-arterial pressure monitoring and Swan Ganz catheterization procedures coupled with the need to retard the retrograde flow of blood is driving a large market adoption. The development of healthcare infrastructure especially trauma care units, intensive care units, and ambulatory surgical centers are driving a large market expanse.

Key Players

Some of the major players in the global pressure infusion cuffs market are VBM Medizintechnik GmbH, ERKA, SSEM Mthembu Medical (Pty) Ltd., Smiths Medical (Smiths Group plc.), Friedrich Bosch GmbH & Co. KG, Biegler GmbH, SARSTEDT AG & Co. KG and others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

Pressure Infusion Cuffs Market: Drivers and Restraints

The development of technology such as the flush valve for regulating the flow of solution coupled with the miniaturization of monitoring devices, ergonomically design, growing use of polyester and nylon material and others is driving a large market. The growing cases of blood transfusion in emergencies coupled with the growing population of geriatric and immunocompromised population is driving a large market.

The restraints on the global pressure infusion cuffs market are the pressure on pricing owing to large market fragmentation, the high volume low value nature of the market which results in price being the most significant value proposition, lack of standardization, low awareness and others.

Pressure Infusion Cuffs Market: Regional Wise Outlook

The global pressure infusion cuffs market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. Asia Pacific market excluding Japan is expected to account for the largest share of the global pressure infusion cuffs market owing to expanding healthcare sector and use of medical devices, and the emergence of China as a large manufacturing base for medical devices. China and India are expected to drive a lion’s share of the pressure infusion cuffs market.

The North America pressure infusion cuffs market is expected to generate a sluggish growth owing to saturation with US leading the pressure infusion cuffs market. Europe market is led by Germany, France and the UK and is expected to be the third largest market.

The Middle East and Africa pressure infusion cuffs market is expected to be dominated by the gulf economies of Saudi Arabia, Kuwait, and Qatar. The poor healthcare expenditure of Africa is a deterrent of the growth of pressure infusion cuffs market.

The report covers exhaust analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain

A Old Full Report Analysis Click Here

Pressure infusion cuffs Market: Segmentation

To gain an accurate understanding of the latest market trends of the global pressure infusion cuffs market, the report is segmented based on applications, coupling mechanism, connectivity mechanism, material of construction, utility, design, end user, and region.

Based on applications, the global pressure infusion cuffs market is segmented into the following:

Blood and Blood Products
Irrigation
Others

Based on size, the global pressure infusion cuffs market is segmented into the following:

Up to 500 ml
Up to 1000 ml
Greater than 1000 ml

Based on material of construction, the global pressure infusion cuffs market is segmented into the following:

Rubber
Polymers
Others

Based on utility, the global pressure infusion cuffs market is segmented into the following:

Disposable
Reusable

Based on end user, the global pressure infusion cuffs market is segmented as below:

Hospitals
Clinics
Ambulatory Surgical Centers

Author By:

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Surgical Tourniquet Market Size to Reach USD 905.1 Million by 2034, Growing at 5.2% CAGR

The anticipated market expansion is driven by the increasing use of surgical tourniquets in various medical procedures, advancements in tourniquet technology, and a rising emphasis on patient safety during surgeries. Surgical tourniquets are essential for controlling blood flow and reducing complications in orthopedic, trauma, and other surgical procedures, further supporting their growing adoption.

To mitigate the risks associated with elevated tourniquet pressures, manufacturers are directing their focus toward product innovations. They are introducing novel features such as automatic pressure control, audiovisual alarms, digital displays, and user-friendly interfaces, aiming to enhance the safety and effectiveness of these medical devices.

Sales of Tourniquet Cuffs to Ramp up in 2019

According to the FMI analysts, tourniquet cuffs have been a vital part of the modern computer-assisted tourniquet system, which accounted for ~77% of total market revenue in 2018. While the inflatable disposable cuffs represented more than half of the total tourniquet cuff sales in 2018, the consumption of inflatable reusable cuffs is likely to increase by 7.6% y-o-y in 2019.

“In terms of tourniquet systems, dual channel systems will continue to represent a relatively high share as compared to single channel systems, in the view of enabling bi-lateral procedures or simultaneous surgeries of both upper and lower extremity,” the FMI analyst said.

The consumption of surgical tourniquets for knee arthroplasty accounted for ~31% of sales in 2018, while increasing application in the amputation of limbs and trauma cases is likely to result in increased market share in the future.

“Recent advancements in reverse shoulder arthroplasty along with the introduction of ‘personalized’ tourniquet systems that allow the use of variable contour design and cuffs for specific patients will open new avenues of growth for the market players,” said the FMI analyst.

Hospitals Capture Significant Share, North America in the Vanguard

In 2018, surgical tourniquets worth ~US$ 176 million were sold in hospitals; according to FMI analysts, a growing number of hospitals, especially in developing countries, and greater awareness of advanced medical devices will continue to drive the consumption of surgical tourniquets in hospitals.

The rapid adoption of the ‘value-based’ model in health care settings has led to a surge in the number of ambulatory surgical centers and specialized clinics, thereby paving a new way of growth for the surgical tourniquets market.

The FMI analyst forecasts that North America will continue to remain at the forefront of the surgical tourniquets market, representing a 30% share in 2018. While North America is likely to be neck-and-neck with Europe to lead the market in the future, manufacturers are tapping into new opportunities in developing countries in the Asia Pacific.

The surgical tourniquets market shows a fair level of fragmentation, with two prominent players Zimmer Biomet and Stryker Corporation accounting for more than one-third of the total revenue share. Exploring unmet needs in developing regions and expanding their distribution through collaboration and acquisitions of local and regional manufacturers remain key focal points of the market players.

A Old Full Report Analysis Click Here

Key Segment

By Product Type

Tourniquet Systems
- Single Channel Systems
- Dual Channel Systems
Tourniquet Cuffs
Inflatable Cuffs
- Disposable Cuffs
- Reusable Cuffs
Non-Inflatable Cuffs
- Disposable Cuffs
- Reusable Cuffs

By Application

Knee Arthroplasty
Amputation of Limbs
Plastic Surgeries
Trauma Cases

By End User

Hospitals
Ambulatory Surgical Centers
Specialized Clinics

By Region

North America
Europe
Latin America
South Asia
East Asia
Oceania
Middle East And Africa
Emerging Countries

About Future Market Insights (FMI)

Contact Us:

Global Clinical Trial Market to Reach USD 184.61 Billion by 2034, Growing at 4.3% CAGR

Pediatric Clinical Trials Market — Clinical Trials Market

The global clinical trial market is expected to experience steady growth over the next decade. Estimated at USD 120.97 billion in 2024, the market is projected to expand at a CAGR of 4.3% during the forecast period from 2024 to 2034, reaching a valuation of USD 184.61 billion by 2034.

The growth in the clinical trial market is driven by increasing investment in drug development, a rising number of chronic diseases, and the need for new therapeutic solutions. Clinical trials are crucial for the advancement of medical research and the introduction of new drugs and treatments to the market.

The expected market growth is fueled by increasing investments in research and development, a growing focus on innovative therapies, and the rising demand for advanced clinical trials across various therapeutic areas. As pharmaceutical and biotechnology companies continue to prioritize clinical trials as a critical component of their development pipelines, the market is poised for robust expansion.

Both governmental and private sponsorship of clinical trials is helping them increase in number. As the number of diseases and patients increases, there is more demand for research to come up with newer medicines and treatments. The rise in cancer patients is especially necessitating the development of more oncology clinical trials.

Clinical trials are making use of advanced technology like AI and machine learning. These technologies are helping researchers handle data, select better samples, save time, and increase effectiveness. Technology is also allowing researchers conduct virtual trials, a holdover from the pandemic era that is still going strong.

There are, however, impediments to market growth. While more people are open to being a part of trials, sometimes researchers struggle to find the right candidates with the right symptoms or afflictions. The complex process of clinical trials, requiring significant funding, is also a roadblock in the path of the market.

Non-small cell lung cancer (NSCLC) and breast cancer were primarily targeted for clinical development among the numerous oncology indications. However, the market for oncology clinical trials is progressively getting more complicated in terms of patient recruitment, clinical trial design elements like outcomes, and more stringent eligibility requirements, among other things.

“Clinical trials are no longer relegated to just labs as decentralized trials that are more convenient for the subjects are emerging as a significant trend. Outsourcing lab work to countries like India and Brazil is also being practiced by companies from developed nations. Thus, outsourcing and decentralized trials represent significant opportunities in the market”, Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)

Key Takeaways from the Clinical Trial Market

The clinical trial market is projected to be valued at USD 120.97 billion in 2024.
Industry sponsorship is the prevailing mode of sponsorship in the market. In 2024, industry sponsorship is projected to account for 55.0% of the market share.
Oncology is the prime area of concern for clinical trials. For 2024, oncology is anticipated to account for 29.7% of the market share by area.
Germany is one of the most promising countries for the market. For the forecast period, the CAGR for Germany is estimated to be 5.6%.
The United Kingdom is another European country with a bright future for the market. The CAGR for the United Kingdom is anticipated to be 4.7% for the forecast period.
The market is expected to register a CAGR of 5.0% in the United States over the forecast period.

What are the Factors Restraining Demand for Clinical Trials?

Patients who match trial selection criteria have become harder to find for businesses. Additionally, the change in medication development efforts to new modalities is intensifying the competition for patients, which makes recruiting more difficult. The typical length of clinical trials has grown as a result of these considerations.

More specifically, as clinical studies move forward, more participants are needed, but the eligibility and appropriateness standards also rise. A patient’s medical history or a mismatch in the stage of their sickness compared to the study protocol may disqualify them from taking part. Patients who are eligible and suitable can find the criteria demanding or the recruitment procedure difficult and time-consuming, or they might not be aware of or compelled to participate.

Another barrier to participation is the cost of frequent clinic visits. The patient population that a novel therapy is anticipated to treat and those taking part in the associated clinical study are also at odds with one another. Patients who are thinking about taking part in a clinical trial for a new drug must balance the advantages of early access to a potential new therapy against the risks of adverse events, as well as the inconvenience, potential financial load, and time commitments.

Clinical trials often encounter challenges such as poor site selection, poor research design, poor trial execution, safety concerns, and dropouts owing to logistical or financial considerations. These factors cumulatively present a limiting impact upon the growth of the overall market during the forecast period.

Competition Analysis of the Clinical Trial Market

Companies in the market are taking the aid of both private and government sponsorships. The nature of the market is fragmented, with scope for organizations of all scales. Some prominent companies in the market include ICON plc, Charles River Laboratories International, Inc., IQVIA, and SYNEOS HEALTH.

Recent Developments in the Clinical Trial Market

In January 2024, Abbott announced the completion of the first trials of the company’s Volt Pulsed Field Ablation (PFA) System for the treatment of heart rhythm disorders.
In August 2023, LG Chem applied to the Italian Medicines Agency for Phase 3 trials of its gout treatment Tigulixostat.

Key Companies in the Clinical Trial Market

Pharmaceutical Product Development, INC. (Thermo Fisher Scientific, Inc.)
ICON plc
Charles River Laboratories International, Inc.
IQVIA
SYNEOS HEALTH
SGS SA
PAREXEL International Corporation
Wuxi AppTec, Inc
Chiltern International Ltd (Laboratory Corporation of America)
Eli Lilly and Company
Novo Nordisk A/S
Pfizer
Clinipace (Caidya)

Category-wise Insights

Which Clinical Trials Sponsor is Driving Market Growth?

The industry sponsor leads the market and the segment will hold a share of around 55% globally, in 2024.

For pharmaceutical and medical device businesses, faster clinical trials are essential because they require a lot of time and money. Due to their increasing complexity and requirement for a bigger patient pool, phase III clinical trials continue to cost more than phase II and phase I trials.

Sponsors are very inclined to believe that developing nations like South Asia and East Asia have more potential for success. Conducting clinical trials in these quickly expanding regions holds forth the possibility of a new range of benefits, including financial incentives and effective regulatory processes, thus benefiting the industry sponsor segment’s growth during the projected period.

What Area of Clinical Trials is Largely in Focus Globally?

The oncology segment will hold a global market share of around 29.7% in 2024.

The cancer therapeutic indication has seen the highest number of new drugs launched globally. The bulk of the leading industrial sponsors of clinical trials contributed significantly to the oncology medicine portfolio.

Among the several oncology indications, clinical development has primarily concentrated on non-small cell lung cancer (NSCLC) and breast cancer. Most firms chose oncology as their primary therapeutic focus since this therapeutic field saw a disproportionately large number of clinical studies begin in comparison to the rest of their individual portfolios. A small number of companies provided a range of therapeutic specializations. Growing interest in the area of oncology will propel the growth of this segment over the projected years.

A Old Full Report Analysis Click Here

Clinical Trial Market Key Segments

By Sponsor:

Industry
Government Organizations
Non-Government Organizations
Others
Associations

By Area:

Oncology
Infectious Diseases
Metabolic Diseases
Cardiovascular Diseases
Neuroscience
Respiratory Diseases
Others

By Phase:

Phase 1
Phase 2
Phase 3
Phase 4

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)

Author by

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Female Stress Urinary Incontinence Treatment Device Market to Reach USD 1,432.0 Million by 2034, Growing at 6.4% CAGR

The global female stress urinary incontinence (SUI) treatment device market is projected to witness robust growth over the next decade. Valued at USD 770.0 million in 2024, the market is anticipated to reach USD 1,432.0 million by 2034, expanding at a CAGR of 6.4% during the forecast period from 2024 to 2034.

Female stress urinary incontinence, a common condition that affects millions of women worldwide, is driving the demand for effective treatment solutions. The market for SUI treatment devices is expected to grow due to increasing awareness, advancements in medical technology, and rising incidences of urinary incontinence among the aging population.

The increasing prevalence of stress urinary incontinence among women and the rising awareness of available treatment options are key factors driving this market expansion. As more women seek effective solutions to manage and alleviate the symptoms of SUI, the demand for advanced treatment devices is expected to rise.

A few medical conditions such as enlarged prostate, muscle damage, excess urine formation, multiple sclerosis, Parkinson’s disease, spinal cord injury, and loss of storage capacity in the rectum are also expected to boost the incidence of stress urinary incontinence among women, which is fuelling the demand for female stress urinary incontinence treatment devices.

The practice of using female stress urinary incontinence treatment devices has changed dramatically over the past decade. The number of procedures undertaken appears to be increasing, and the shift in relative numbers of different procedures has been remarkable. For instance, in England, the annual number of operations undertaken using female stress urinary incontinence treatment devices between 1997-1998 and 2005-2006 increased by 28%, despite a reduction of over 90% in the number of colposuspension and needle suspension procedures.

Healthy Revenue Growth Projected Through 2029

According to the latest research by FMI, the Global Female Stress Urinary Incontinence Treatment Devices Industry is estimated to have accounted for ~ US$ 560 Mn in terms of value in 2018. The report on the female stress urinary incontinence treatment devices market further projects that the Global Female Stress Urinary Incontinence Treatment Devices Industry is likely to grow at a CAGR of ~ 6% during the period 2019-2029.

However, due to the presence of a wide range of products in the Global Female Stress Urinary Incontinence Treatment Devices Industry , small players are gaining interest and are selling their products at a lower price. An increase in the penetration of private-label brands at much lower prices is expected to decrease the average overall price of female stress urinary incontinence treatment devices. This is likely to restrain the growth of the Global Female Stress Urinary Incontinence Treatment Devices Industry, as it is likely to hamper the demand for expensive products.

Rapid changes have taken place in developing countries over the past few years. The improper implementation of regulatory guidelines and the lack of proper healthcare infrastructure in developing regions, such as the Middle East & Africa, and Latin America, are among the factors that are expected to restrain the growth of the Global Female Stress Urinary Incontinence Treatment Devices Industry.

50% Revenue Shares Accounted by North America

The female stress urinary incontinence treatment devices market has been analyzed across the regions of North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa. North America, followed by Europe, is a prominent region in the Global Female Stress Urinary Incontinence Treatment Devices Industry . North America accounted for a revenue share of about 50% in 2018 in the female stress urinary incontinence treatment devices market. Europe also accounted for a prominent revenue share and is followed by East Asia in the female stress urinary incontinence treatment devices market.

The Global Female Stress Urinary Incontinence Treatment Devices Industry report tracks some of the key companies operating in female stress urinary incontinence treatment devices market, such as Boston Scientific Corporation, BD, Coloplast Corporation, Caldera Medical, and Ethicon US LLC (Johnson & Johnson Services, Inc.). The majority of the key regional players in the Global Female Stress Urinary Incontinence Treatment Devices Industry are highly focused on expanding their product connectivity and reach with the help of domestic distributors of female stress urinary incontinence treatment devices. Moreover, the manufacturers of female stress urinary incontinence treatment devices are focused on strengthening their businesses in high-growth markets, such as India, Japan, and China, by expanding their distribution and sales channels.

Key Segments Of Female Stress Urinary Incontinence Treatment Devices Industry Survey Global Female Stress Urinary Incontinence Treatment Devices Industry by Product Type:

Sling Systems
- Mid-Urethral Slings
- Sub-Urethral Slings
Pessaries
Artificial Urinary Sphincters (AUS)
Injectable Urethral Bulking Agents

Global Female Stress Urinary Incontinence Treatment Devices Industry by End Use:

Female Stress Urinary Incontinence Treatment Devices for Hospitals
Female Stress Urinary Incontinence Treatment Devices for Gynaecological Clinics
Female Stress Urinary Incontinence Treatment Devices for Homecare Settings

Global Female Stress Urinary Incontinence Treatment Devices Industry by Region:

North America Female Stress Urinary Incontinence Treatment Devices Market
Latin America Female Stress Urinary Incontinence Treatment Devices Market
Europe Female Stress Urinary Incontinence Treatment Devices Market
East Asia Female Stress Urinary Incontinence Treatment Devices Market
South Asia & Pacific Female Stress Urinary Incontinence Treatment Devices Market
Middle East & Africa (MEA) Female Stress Urinary Incontinence Treatment Devices Market

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Driving Growth: The Rising Demand for Potassium Sulfate in the USA and Canada Agriculture Sector

The Potassium Sulfate market in the USA and Canada is currently valued at approximately USD 426.2 million and is expected to grow to USD 564.4 million by 2032. This growth reflects a projected increase in demand at a compound annual growth rate (CAGR) of 2.8% from 2022 to 2032. Factors driving this expansion include rising agricultural applications and increasing adoption of potassium sulfate in industrial processes across both countries. These trends highlight a promising trajectory for the potassium sulfate market in North America over the next decade.

Changing preferences towards less toxic and chlorine-free fertilizers across booming agriculture industry and increasing need for improving crop yields are some of the key factors driving the U.S. and Canada Potassium Sulfate market.

Significant production volume of crops across the North America is consuming enormous volumes of fertilizers like potassium chloride and Potassium Sulfate. However, FMI predicts the consumption of Potassium Sulfate to increase at a significant pace as it does not contain chloride, which can be harmful to some crops. This will accelerate growth in the USA and Canada Potassium Sulfate industry.

Similarly, the need for potassium and sulfur nutrients for healthy growth of crops is prompting farmers across North American countries to use Potassium Sulfate. Fertilizers such as sulphate of potassium (SOP fertilizer) support plant growth and increases crop yield. Hence, growing focus on increasing crop yield will elevate Potassium Sulfate demand across the U.S. and Canada.

Key Potassium Sulfate companies are focusing on increasing their market presence by enhancing their production capacities and by acquisition of small and medium-sized market participants. Several end users and distributors import Potassium Sulfate from other countries to meet the growing demand in the country and also due to low prices. Increasing presence in the untapped market is also a key growth strategy of the players.

Subsequently, the Potassium Sulfate market is significantly influenced by research and development in environment-friendly fertilizers, multi-nutrient fertilizers. Based on these factors significant investment has been made in developing Potassium Sulfate from eco-friendly materials and processes, which is expected to fuel the demand for Potassium Sulfate in the forecast period.

“Farming process in the North America is growing in terms of technology as well as sustainability, where environment-friendly crop nutrients like Potassium Sulfate are being preferred as compared to their counterpart fertilizers from the end users,” says an FMI analyst.

Key Takeaways:

The global market of Potassium Sulfate is projected to witness a CAGR of magnitude 2.8% during the forecast period of 2022 and 2032.
By product form, granular Potassium Sulfate is estimated to account for about 65% of the overall market size.
Based on application, tree nuts segment is expected to capture a significant portion of the U.S. and Canada Potassium Sulfate market during the forecast period.
The U.S. remains the leading consumer of Potassium Sulfate across the North America and the trend is expected to continue during the forecast period.
Canada’s Potassium Sulfate market is likely to grow at a moderate CAGR during the forecast period.

Who is Winning?

The market of Potassium Sulfate is estimated to be a consolidated market, where key players are expected to account for more than 50% share of the market. Compass Minerals International, Inc., The Mosaic Company, SOPerior Fertilizer Corp., Tessenderlo Kerley, Inc., Interpid Potash, Inc., K+S North America Corporation, and many others are some of the manufacturers of Potassium Sulfate profiled in the full version of the report.

Key players are focusing on expanding their production capacity to meet the growing market demand and strengthening their distribution network to increase their market presence all over the region and to gain maximum traction in the market. Further top players are also investing significantly in innovation in the product series.

Get the Insights You Need – Connect with Sales to Secure Your Copy of Report

Potassium Sulfate Industry Segmentation

By Product Form:

Granular
Powder
Liquid

By Application:

Tree nuts
Fruits
Vegetables
Tobacco
Others

By Country:

USA
Canada

About Future Market Insights (FMI)

Contact Us:

Network Security Policy Management Market 2022 Future Analysis, Demand by Regions and Opportunities with Challenges 2032

Network security policy management market is predicted to grow at a compound annual growth rate (CAGR) of 6.7% between 2022 and 2032.The market for network security policy management is projected to generate US$ 3.6 billion by 2032, up from US$ 1.9 billion in 2022.

Because it guards against both online threats and the expanding volume of online transactions and activities, network security policy management is becoming more and more popular.

Network security policy management has become more and more popular as a result of the growing trend of digital payments, which exposes a lot of private information, including credit card numbers, bank account details, and personal information.

The Network Security Policy Management Market refers to the industry that provides solutions and services for managing and enforcing network security policies across an organization’s network infrastructure. Network security policies are a set of rules and guidelines that dictate how network traffic is handled and managed to ensure the security and integrity of the network.

The Network Security Policy Management Market is driven by the increasing complexity of network infrastructure and the growing number of security threats. As organizations expand their networks, it becomes more challenging to manage and enforce security policies across multiple devices and locations. Network security policy management solutions help organizations to automate the process of creating, enforcing, and managing security policies across their entire network infrastructure.

How Strong is the Competition in the Network Security Policy Management Market?

There is comparatively less competition in the network security policy management market. However, network security policy management market growth is rapidly increasing as new businesses are expected to emerge during the forecast period.

There are also network security policy management market opportunities for large corporations to invest in the market. The security policy management vendors are working to raise awareness about security solutions.

Product changes and technological advancements are examples of market developments. During this time, the market’s key players are forming new alliances and planning market expansion strategies in order to consolidate their market position by expanding their network security policy management market share.

Vital Market Players include:

AlgoSec Inc.
Palo Alto Networks, Inc.
Check Point Software Technologies Ltd.
FireMon, LLC.
Forcepoint LLC

Key Segments:

By Component:

Software
- Cloud-Based
- On-Premise
Services
- Professional Services
- Managed Services

By Solution:

Security Policy Management
Change Management System
Risk and Vulnerability Analysis
Application Connectivity Management

By End-use:

Banking
Financial Services and Insurance (BFSI)
Healthcare, Government
IT & Telecom, Retail, Transportation
Energy & Utilities
Others

By Enterprise Size:

Small & Medium Enterprises (SMEs)
Large Enterprises

By Region:

North America
Europe
Asia Pacific
Middle East & Africa
South America

Click to Buy Your Exclusive Report Immediately!

About Future Market Insights (FMI)

Contact Us: